ASCO 2017- CALGB-ECOG 100104 Alliance study- Lenalidomide vs placebo maintenance after stem cell transplant

Background: At a prespecified interim analysis (Dec 2009), the phase 3 CALGB study results surpassed the prespecified superiority boundary (significantly improved PFS for LEN maint vs PBO after SCT) a... Author: InternationalMyelomaFoundation Added: 08/15/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts